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Among immune system dendritic cells (DCs), Langerhans cells (LCs) - found 
in stratified squamous epithelia - express langerin/CD207 and CD1a and contain 
Birbeck granules, while connective tissue DCs express DC-SIGN intensely. DCs may 
be generated in vitro from monocytes and from immature haematopoietic precur-
sors; PPAR (peroxisome proliferator activated receptor)-gamma stimulation can direct 
CD133+ precursors to generate DCs with a LC phenotype [1]. In order to achieve 
deeper knowledge on human DC subtypes differentiation, circulating CD14+ mono-
cytes have been isolated by immunomagnetic separation and cultured with GM-CSF, 
IL-4, and TGF-beta for 7 days. Maturation was induced by further culture for 48 h 
with TNF-alpha, IL-1 beta and IL-6 [2]. Rosiglitazone was used to stimulate PPAR-
gamma. The cells were analysed by phase contrast and electron microscopy and by 
immunofluorescence. Both with and without rosiglitazone, cells with a dendritic 
shape were generated together with non-dendritic, elongated cells with the aspect 
of anti-inflammatory (M2) macrophages. All the generated, mature cells expressed 
MHC-II intensely. DCs grown with rosiglitazone were CD207-, while those grown 
without rosiglitazone appeared CD207+; in neither conditions did cells contain 
Birbeck granules, while in both conditions DCs expressed DC-SIGN, more intensely 
with than without rosiglitazone. Elongated non-dendritic cells expressed CD14 more 
intensely than DCs, and CD80, CD83 and CD86 as intensely as DCs. The results indi-
cate that upon addiction of rosiglitazone the differentiation of cultured monocytes to 
LCs is hampered, at variance with what happens with cultures of CD133+ precursors. 
They also indicate that the generation of non-dendritic elongated cells, possibly M2 
macrophages, can occur in association with that of dendritic cells.
References
[1] Bonetti M.I. et al. (2014) Rosiglitazone promotes the differentiation of Langerhans cells and inhib-
its that of other dendritic cell types from CD133 positive hematopoietic precursors. Histol. Histo-
pathol. 29:323-332.
[2] Bellik L. et al. (2006) Role of conventional treatments on circulating and monocyte-derived den-
dritic cells in colorectal cancer. Clin Immunol 121: 74-80.
Keywords
Cell culture, electron microscopy, immunofluorescence, Langerhans cells, monocytes, PPAR-
gamma.
